Cambridge Investment Research Advisors
DCOY

Cambridge Investment Research Advisors’s Decoy Therapeutics DCOY Stock Holding History

Cambridge Investment Research Advisors’s Portfolio DCOY Stock Details DCOY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1
Closed -$4K – 3203
2022
Q3 		$4K Hold
1
– – ﹤0.01% 3038
2022
Q2 		$4K Hold
1
– – ﹤0.01% 3034
2022
Q1 		$8K Buy
+1
New +$15.8K ﹤0.01% 3147
2019
Q1 		– Hold
0
– -$3K – 2348
2018
Q4 		– Hold
0
– – – 2144

Other funds holding DCOY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $501B AUM 22.01% 1-Year Est. Return